Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A Prospective, Randomized, Controlled Pilot Trial

Overview

Journal Nutrients

Date 2021 Jun 2

PMID 34070910

Citations 10

Authors

Tomomi Okubo

Masanori Atsukawa

Akihito Tsubota

Hiroki Ono

Tadamichi Kawano

Yuji Yoshida

Taeang Arai

Korenobu Hayama

Norio Itokawa

Chisa Kondo

Keiko Kaneko

Katsuhiko Iwakiri

Affiliations

Soon will be listed here.

Abstract

Background: Sarcopenia worsens patient prognoses in chronic liver disease. This study aimed to elucidate the effects of vitamin D supplementation on skeletal muscle volume and strength in patients with decompensated cirrhosis.

Methods: Thirty-three patients were entered into the study based on the criteria and then randomly assigned to two groups: Group A ( = 17), the control group, and Group B ( = 16), those who received oral native vitamin D3 at a dose of 2000 IU once a day for 12 months.

Results: SMI values in Group B were significantly increased at 12 months (7.64 × 10). The extent of changes in the SMI and grip strength in Group B were significantly greater than that in Group A at 12 months ( = 2.57 × 10 and 9.07 × 10). The median change rates in the SMI were +5.8% and the prevalence of sarcopenia was significantly decreased from 80.0% (12/15) to 33.3% (5/15; = 2.53 × 10) in Group B.

Conclusions: Vitamin D supplementation might be an effective and safe treatment option for patients with decompensated cirrhosis to increase or restore the skeletal muscle volume and strength or prevent the muscle volume and strength losses.

Citing Articles

Efficacy of different nutrition interventions on sarcopenia in patients with cirrhosis: a systematic review and network meta-analysis.

Sobhrakhshankhah E, Farahmand M, Hasan Rashedi M, Shahinfar H, Shab-Bidar S, Dinari S BMC Nutr. 2025; 11(1):39.

PMID: 39940017 PMC: 11817602. DOI: 10.1186/s40795-025-01028-y.

No causal association between serum vitamin D levels and bronchiectasis: A Mendelian randomization analysis.

Pan W, Huang Z, Deng H, Huang H, Yu K Medicine (Baltimore). 2024; 103(49):e40824.

PMID: 39654221 PMC: 11630948. DOI: 10.1097/MD.0000000000040824.

Non-Pharmacological Strategies for Managing Sarcopenia in Chronic Diseases.

Hu J, Wang Y, Ji X, Zhang Y, Li K, Huang F Clin Interv Aging. 2024; 19:827-841.

PMID: 38765795 PMC: 11102744. DOI: 10.2147/CIA.S455736.

Low vitamin D levels accelerates muscle mass loss in patients with chronic liver disease.

Okubo T, Atsukawa M, Tsubota A, Ono H, Kawano T, Yoshida Y PLoS One. 2024; 19(3):e0299313.

PMID: 38530830 PMC: 10965050. DOI: 10.1371/journal.pone.0299313.

Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases.

Espina S, Casas-Deza D, Bernal-Monterde V, Domper-Arnal M, Garcia-Mateo S, Lue A Nutrients. 2023; 15(15).

PMID: 37571424 PMC: 10421025. DOI: 10.3390/nu15153487.

References

Ninomiya G, Fujii T, Yamada S, Yabusaki N, Suzuki K, Iwata N . Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study. Int J Surg. 2017; 39:45-51. DOI: 10.1016/j.ijsu.2017.01.075. View

Hayashi F, Matsumoto Y, Momoki C, Yuikawa M, Okada G, Hamakawa E . Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis. Hepatol Res. 2013; 43(12):1264-75. DOI: 10.1111/hepr.12085. View

Ceglia L, Harris S . Vitamin D and its role in skeletal muscle. Calcif Tissue Int. 2012; 92(2):151-62. DOI: 10.1007/s00223-012-9645-y. View

Dattola A, Silvestri M, Bennardo L, Passante M, Scali E, Patruno C . Role of Vitamins in Skin Health: a Systematic Review. Curr Nutr Rep. 2020; 9(3):226-235. DOI: 10.1007/s13668-020-00322-4. View

Iwasa M, Sugimoto R, Takei Y . Patients with hyponatremic cirrhosis have low-grade cerebral edema and poor quality-of-life. Ann Hepatol. 2014; 13(3):407-8. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Arai T, Atsukawa M, Tsubota A, Koeda M, Yoshida Y, Okubo T . Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. Dig Liver Dis. 2019; 51(7):1036-1042. DOI: 10.1016/j.dld.2018.12.022. View

Wicherts I, van Schoor N, Boeke A, Visser M, Deeg D, Smit J . Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab. 2007; 92(6):2058-65. DOI: 10.1210/jc.2006-1525. View

Benadon B, Servagi-Vernat S, Quero L, Cattan P, Guillerm S, Hennequin V . Sarcopenia: An important prognostic factor for males treated for a locally advanced esophageal carcinoma. Dig Liver Dis. 2020; 52(9):1047-1052. DOI: 10.1016/j.dld.2020.04.009. View

10.

Kitajima Y, Takahashi H, Akiyama T, Murayama K, Iwane S, Kuwashiro T . Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis. J Gastroenterol. 2017; 53(3):427-437. DOI: 10.1007/s00535-017-1370-x. View

11.

Visser M, Deeg D, Lips P . Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003; 88(12):5766-72. DOI: 10.1210/jc.2003-030604. View

12.

Saeki C, Kanai T, Nakano M, Oikawa T, Torisu Y, Saruta M . Low Serum 25-Hydroxyvitamin D Levels Are Related to Frailty and Sarcopenia in Patients with Chronic Liver Disease. Nutrients. 2020; 12(12). PMC: 7764249. DOI: 10.3390/nu12123810. View

13.

Nishikawa H, Shiraki M, Hiramatsu A, Moriya K, Hino K, Nishiguchi S . Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res. 2016; 46(10):951-63. DOI: 10.1111/hepr.12774. View

14.

Bischoff-Ferrari H, Borchers M, Gudat F, Durmuller U, Stahelin H, Dick W . Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res. 2004; 19(2):265-9. DOI: 10.1359/jbmr.2004.19.2.265. View

15.

Garcia-Pagan J, Santos C, Barbera J, Luca A, Roca J, Rodriguez-Roisin R . Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology. 1996; 111(5):1300-6. DOI: 10.1053/gast.1996.v111.pm8898644. View

16.

Hayashi M, Abe K, Fujita M, Okai K, Takahashi A, Ohira H . Association between sarcopenia and osteoporosis in chronic liver disease. Hepatol Res. 2018; 48(11):893-904. DOI: 10.1111/hepr.13192. View

17.

McPherron A, Lawler A, Lee S . Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997; 387(6628):83-90. DOI: 10.1038/387083a0. View

18.

Suzuki T, Kwon J, Kim H, Shimada H, Yoshida Y, Iwasa H . Low serum 25-hydroxyvitamin D levels associated with falls among Japanese community-dwelling elderly. J Bone Miner Res. 2008; 23(8):1309-17. DOI: 10.1359/jbmr.080328. View

19.

Bischoff H, Stahelin H, Dick W, Akos R, Knecht M, Salis C . Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res. 2003; 18(2):343-51. DOI: 10.1359/jbmr.2003.18.2.343. View

20.

Schwalfenberg G . Not enough vitamin D: health consequences for Canadians. Can Fam Physician. 2007; 53(5):841-54. PMC: 1949171. View